4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001714899-22-000146
Director sold 20,000 shares at an average $30.27 ($605,463)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Tessier-Lavigne Marc Director | 2022-11-01 | Sale | −8,748 | $30.20 | $264,190 | 1,901,608 | D |
| Tessier-Lavigne Marc Director | 2022-11-02 | Sale | −11,252 | $30.33 | $341,273 | 1,890,356 | D |
| Open-market sales · 20,000 sh · avg $30.27 · $605,463 | |||||||
Loading xslF345X03/wf-form4_166751143725460.xml…